These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 17932424

  • 1. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes.
    Urbán VS, Kiss J, Kovács J, Gócza E, Vas V, Monostori E, Uher F.
    Stem Cells; 2008 Jan; 26(1):244-53. PubMed ID: 17932424
    [Abstract] [Full Text] [Related]

  • 2. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
    Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yañez AJ, Conget PA.
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of stem cell differentiation in diabetic rats transplanted with bone marrow mesenchymal stem cells.
    Lin P, Chen L, Yang N, Sun Y, Xu YX.
    Transplant Proc; 2009 Jun; 41(5):1891-3. PubMed ID: 19545751
    [Abstract] [Full Text] [Related]

  • 4. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro.
    Sun Y, Chen L, Hou XG, Hou WK, Dong JJ, Sun L, Tang KX, Wang B, Song J, Li H, Wang KX.
    Chin Med J (Engl); 2007 May 05; 120(9):771-6. PubMed ID: 17531117
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic potential of non-adherent BM-derived mesenchymal stem cells in tissue regeneration.
    Zhang ZL, Tong J, Lu RN, Scutt AM, Goltzman D, Miao DS.
    Bone Marrow Transplant; 2009 Jan 05; 43(1):69-81. PubMed ID: 18711348
    [Abstract] [Full Text] [Related]

  • 6. Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia.
    Boumaza I, Srinivasan S, Witt WT, Feghali-Bostwick C, Dai Y, Garcia-Ocana A, Feili-Hariri M.
    J Autoimmun; 2009 Feb 05; 32(1):33-42. PubMed ID: 19062254
    [Abstract] [Full Text] [Related]

  • 7. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model.
    Kuo YR, Goto S, Shih HS, Wang FS, Lin CC, Wang CT, Huang EY, Chen CL, Wei FC, Zheng XX, Lee WP.
    Transplantation; 2009 Jun 27; 87(12):1769-77. PubMed ID: 19543052
    [Abstract] [Full Text] [Related]

  • 8. [Experiment study of efficacy on hematopoietic reconstitution and GVHD prophylaxis after mesenchymal cell infused by intra-bone marrow cavity or intravenous in rat BMT models].
    Huang K, Huang SL, Zhou DH, Cai Y, Zhang XC, Li Y.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb 27; 28(2):87-92. PubMed ID: 17650667
    [Abstract] [Full Text] [Related]

  • 9. Characterization of EGFP-labeled mesenchymal stem cells and redistribution of allogeneic cells after subcutaneous implantation.
    Duan X, Yang L, Dong S, Xin R, Chen G, Guo L.
    Arch Orthop Trauma Surg; 2008 Jul 27; 128(7):751-9. PubMed ID: 18265994
    [Abstract] [Full Text] [Related]

  • 10. Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats.
    Figliuzzi M, Cornolti R, Perico N, Rota C, Morigi M, Remuzzi G, Remuzzi A, Benigni A.
    Transplant Proc; 2009 Jun 27; 41(5):1797-800. PubMed ID: 19545731
    [Abstract] [Full Text] [Related]

  • 11. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
    Prigozhina TB, Khitrin S, Elkin G, Eizik O, Morecki S, Slavin S.
    Exp Hematol; 2008 Oct 27; 36(10):1370-6. PubMed ID: 18619727
    [Abstract] [Full Text] [Related]

  • 12. A new bone marrow transplantation method for stem cell disorders.
    Ikehara S.
    Ann N Y Acad Sci; 2009 Sep 27; 1173():774-80. PubMed ID: 19758228
    [Abstract] [Full Text] [Related]

  • 13. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH, Li XY, Ding J, Jia JF, Zhu P.
    Rheumatology (Oxford); 2008 Jan 27; 47(1):22-30. PubMed ID: 18077486
    [Abstract] [Full Text] [Related]

  • 14. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.
    Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, Slavin S, Abramsky O, Karussis D.
    Arch Neurol; 2008 Jun 27; 65(6):753-61. PubMed ID: 18541795
    [Abstract] [Full Text] [Related]

  • 15. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation.
    Maitra B, Szekely E, Gjini K, Laughlin MJ, Dennis J, Haynesworth SE, Koç ON.
    Bone Marrow Transplant; 2004 Mar 27; 33(6):597-604. PubMed ID: 14716336
    [Abstract] [Full Text] [Related]

  • 16. Intra-bone marrow-bone marrow transplantation: a new strategy for treatment of stem cell disorders.
    Ikehara S.
    Ann N Y Acad Sci; 2005 Jun 27; 1051():626-34. PubMed ID: 16127003
    [Abstract] [Full Text] [Related]

  • 17. Effect of bone marrow-derived mesenchymal stem cells on cardiovascular complications in diabetic rats.
    Abdel Aziz MT, El-Asmar MF, Haidara M, Atta HM, Roshdy NK, Rashed LA, Sabry D, Youssef MA, Abdel Aziz AT, Moustafa M.
    Med Sci Monit; 2008 Nov 27; 14(11):BR249-55. PubMed ID: 18971868
    [Abstract] [Full Text] [Related]

  • 18. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
    Ishikane S, Ohnishi S, Yamahara K, Sada M, Harada K, Mishima K, Iwasaki K, Fujiwara M, Kitamura S, Nagaya N, Ikeda T.
    Stem Cells; 2008 Oct 27; 26(10):2625-33. PubMed ID: 18669910
    [Abstract] [Full Text] [Related]

  • 19. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis.
    Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G.
    Arthritis Rheum; 2007 Apr 27; 56(4):1175-86. PubMed ID: 17393437
    [Abstract] [Full Text] [Related]

  • 20. Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.
    Ezquer F, Ezquer M, Simon V, Pardo F, Yañez A, Carpio D, Conget P.
    Biol Blood Marrow Transplant; 2009 Nov 27; 15(11):1354-65. PubMed ID: 19822294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.